Science

BioWorld MedTech’s Diagnostics Extra for Feb. 13, 2020

February 13, 2020

Keeping you up to date on recent developments in diagnostics, including: Creating a safer MRI contrast agent; Novel blood test for HPV-related head and neck cancer; More enhancers suggest more pathogenicity: study; Distinguishing real from backseat drivers.

BioWorld MedTech’s Orthopedics Extra for Feb. 12, 2020

February 12, 2020

By Holland Johnson

No Comments

Keeping you up to date on recent developments in orthopedics, including: Using bone’s natural electricity to promote regeneration; Puregraft reports successful phase IIa trial results for KO; Bioventus updates U.S. label for Exogen ultrasound bone healing system; Injectable drug for faster healing of bone fractures prepares for clinical trials (Novosteo).

The long and short of it

Prolactin could explain sex differences in pain syndromes

February 12, 2020

By Anette Breindl

No Comments

The hormone prolactin is known for and named after its role in breastfeeding. But that is far from its only role. There are more than 300 identified functions of prolactin, which is present in both men and women, though women have higher levels, and extremely high levels late in pregnancy and during breastfeeding. Now, scientists at the University of Arizona have identified another function of prolactin signaling.

Ebola, malaria, HIV, TCM

Researchers cast wide net for rapid-draw weapons in 2019-nCoV fight

February 11, 2020

By Anette Breindl

No Comments

At this very early point in the emerging 2019-nCoV outbreak, knowledge about the virus is insufficient to predict what shape that outbreak will ultimately take.

Not yet a pandemic, 2019-nCoV has echoes of MERS, SARS, flu

February 11, 2020

By Anette Breindl

No Comments

The drug screens prompted by the SARS and MERS outbreaks have been useful for quickly identifying drug candidates. But in terms of their epidemiology, “SARS and MERS were different from this coronavirus,” Allison McGeer explained at a Feb. 3 webinar by Evercore ISI.

BioWorld MedTech’s Oncology Extra for Feb. 11, 2020

February 11, 2020

By Mark McCarty and Anette Breindl

No Comments

Keeping you up to date on recent developments in oncology, including: Study bolsters case for maximal resection for glioblastoma; CD47 knockout improves antitumor vaccine; Distinguishing real from backseat drivers; Protons come to American state of Alabama.

Pan-Cancer Project looks closer, sees more

February 11, 2020

By Nuala Moran

No Comments

LONDON – The genomes of 38 different tumor types and the 47 million mutations that fostered their growth are revealed in unprecedented detail in 23 studies published in Nature and other journals on Feb. 6, 2020.

BioWorld MedTech’s Cardiology Extra for Feb. 10, 2020

February 10, 2020

By Liz Hollis

No Comments

Keeping you up to date on recent developments in cardiology, including: Researchers find 'first responder' that triggers plaques; Heart muscle cells alter their energy source during regeneration; More evidence points to rosiglitazone, heart issues.

Science-Credit-University-of-Texas-Southwestern-Medical-Center-2-10

Decoding depression

EEG signature can predict response to SSRIs

February 10, 2020

By Anette Breindl

No Comments

For depression, and other mental health disorders, the era of precision medicine has yet to arrive. Symptoms are “very poorly reflective of the underlying biology,” Amit Etkin told BioWorld. Depression can manifest through multiple different symptoms that differ both between and within cultures.

BioWorld MedTech’s Neurology Extra for Feb. 7, 2020

February 7, 2020

By Andrea Applegate and Anette Breindl

No Comments

Keeping you up to date on recent developments in neurology, including: Online therapy for lingering depression could fill gap in care; UTHealth develops technology to differentiate between PD and multiple system atrophy; Myelin is deregulated in autism spectrum disorder.